Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | -36,951 | 19,823 | 18,415 | 18,414 | 14,388 |
| Operating Income | 36,951 | -19,823 | -18,415 | -18,414 | -14,388 |
| Other Income | -1,286 | 812 | 319 | 155 | 147 |
| Pre-tax Income | 35,665 | -19,011 | -18,096 | -18,259 | -14,241 |
| Net Income Continuous | 35,665 | -19,011 | -18,096 | -18,259 | -14,241 |
| Net Income | $35,665 | $-19,011 | $-18,096 | $-18,259 | $-14,241 |
| EPS Basic Total Ops | -8.97 | -4.59 | -4.40 | -4.50 | 3.90 |
| EPS Basic Continuous Ops | -9.01 | -4.59 | -4.40 | -4.46 | 3.89 |
| EPS Diluted Total Ops | -8.97 | -4.59 | -4.40 | -4.50 | 3.90 |
| EPS Diluted Continuous Ops | -9.01 | -4.59 | -4.40 | -4.46 | 3.89 |
| EBITDA(a) | $35,969 | $-19,782 | $-17,959 | $-17,923 | $-14,151 |